Adjuvant systemic therapy: the issues of timing and sequence.

Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer

Volumn 140, Issue , 1996, Pages 201-213

  Castiglione Gertsch, M ^a   Gelber, R D ^a   Goldhirsch, A ^a  

^a International Breast Cancer Study Group Coordinating Center   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ADJUVANT CHEMOTHERAPY; BREAST TUMOR; CLINICAL TRIAL; FEMALE; HUMAN; LYMPH NODE METASTASIS; PATHOLOGY; REVIEW; SURVIVAL; TIME; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; FEMALE; HUMANS; LYMPHATIC METASTASIS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 0029694294     PISSN: 00800015     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-3-642-79278-6_23     Document Type: Review

References (22)